Nzerem; Jerry

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nzerem; Jerry.The latest application filed is for "crystalline form of a dihydrochloride salt of a jak inhibitor compound".

Company Profile

8.14.16

Nzerem; Jerry - South San Francisco CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Crystalline Form Of A Dihydrochloride Salt Of A Jak Inhibitor Compound App 20220306626 - Nzerem; Jerry ; et al.	2022-09-29
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20220119369 - McKinnell; Robert Murray ; et al.	2022-04-21
Fused imidazo-piperidine JAK inhibitor compound Grant 11,160,810 - McKinnell , et al. November 2, 2	2021-11-02
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant 10,968,205 - McKinnell , et al. April 6, 2	2021-04-06
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20200216423 - MCKINNELL; ROBERT MURRAY ; et al.	2020-07-09
Fused Imidazo-piperidine Jak Inhibitor Compound App 20200046719 - MCKINNELL; ROBERT MURRAY ; et al.	2020-02-13
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant 10,538,513 - McKinnell , et al. Ja	2020-01-21
Fused imidazo-piperidine JAK inhibitor compound Grant 10,493,077 - Fatheree , et al. De	2019-12-03
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20190315724 - MCKINNELL; ROBERT MURRAY ; et al.	2019-10-17
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors Grant 10,392,368 - Fenster , et al. A	2019-08-27
Pyrimidine compound as JAK kinase inhibitor Grant 10,308,646 - Kozak , et al.	2019-06-04
Pyrimidine Compound As Jak Kinase Inhibitor App 20190127364 - KOZAK; JENNIFER ; et al.	2019-05-02
Crystalline forms of a JAK inhibitor compound Grant 10,251,874 - Dabros , et al.	2019-04-09
Pyrazolo And Triazolo Bicyclic Compounds As Jak Kinase Inhibitors App 20190040043 - FENSTER; ERIK ; et al.	2019-02-07
Fused Imidazo-piperidine Jak Inhibitor Compound App 20180311255 - FATHEREE; PAUL R. ; et al.	2018-11-01
Crystalline Forms Of A Jak Inhibitor Compound App 20180311223 - DABROS; MARTA ; et al.	2018-11-01
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid Grant 9,868,698 - Hughes , et al. January 16, 2	2018-01-16
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid App 20170355665 - Hughes; Adam D. ; et al.	2017-12-14
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xmethyl-2-methylpentanoic acid Grant 9,670,143 - Hughes , et al. June 6, 2	2017-06-06
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid App 20170088508 - Hughes; Adam D. ; et al.	2017-03-30
(2S,4R)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- xymethyl-2-methylpentanoic acid Grant 9,433,598 - Hughes , et al. September 6, 2	2016-09-06
(2s,4r)-5-(5'-chloro-2'-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydro- Xymethyl-2-methylpentanoic Acid App 20160228395 - Hughes; Adam D. ; et al.	2016-08-11
Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl- )hydrazino]-2-hydroxyproprionic acid isopropyl ester Grant 9,271,965 - Thalladi , et al. March 1, 2	2016-03-01
Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitor Grant 8,883,135 - Thalladi , et al. November 11, 2	2014-11-11
Crystalline Form Of A Pyridyl-piperazinyl Hepatitis C Virus Inhibitor App 20130295048 - Thalladi; Venkat R. ; et al.	2013-11-07
Crystalline Forms Of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl- )hydrazino]-2-hydroxypropionic Acid Isopropyl Ester App 20130259897 - Thalladi; Venkat R. ; et al.	2013-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.